Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cell-free DNA concentration is significantly increased in the first 2 weeks after surgery but these higher levels do not seem to interfere with monitoring of circulating tumor DNA for prognostic purposes.
Item 2.02. Results of Operations and Financial Condition. On November 9, 2022, Aadi Bioscience, Inc. issued a press release announcing its financial results for the fiscal quarter ended September... | November 9, 2022
LOS ANGELES, Nov. 8, 2022 /PRNewswire/ -- Aadi Bioscience, Inc. , a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR... | November 9, 2022
GuruFocus Article or News written by PRNewswire and the topic is about:
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter of...